Medicine
Phenoxybenzamine 10 mg capsule
Phenoxybenzamine 10 mg capsule is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage as on the product label
Key facts
- Active ingredient (INN)
- Phenoxybenzamine
- Brand
- Sold under the generic name
- Strength
- 10 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules and 2 more
- Manufacturers
- Aurobindo PharmaIndiaAmneal Pharmaceuticals NYBurel PharmaceuticalsNovitium PharmaRising Pharma Holdings
- Origin register
- US FDA, United States
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C04AX02 Phenoxybenzamine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 October 2020
- Identifiers
- RxCUI 861402DailyMed set ID 0be6a394-cd10-42fc-97cf-ad53d81d8d93, 2cb5fcd7-c37f-41de-8beb-0c7eded9ed04, 1d2108fa-4352-4f3f-9314-732ed8b6394c +2NDC 60219-1502, 70954-365, 16571-874 +2Application ANDA212568, ANDA215042, ANDA204551 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 59651-327-01 | Aurobindo PharmaIndia | 8 May 2023 |
| 100 capsule in 1 bottle | 60219-1502-1 | Amneal Pharmaceuticals NY | 30 October 2020 |
| 100 capsule in 1 bottle | 35573-473-02 | Burel Pharmaceuticals | 8 May 2023 |
| 100 capsule in 1 bottle | 70954-365-10 | Novitium Pharma | 19 July 2022 |
| 100 capsule in 1 bottle | 16571-874-01 | Rising Pharma Holdings | 26 August 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 26 January 1953 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Phenoxybenzamine is an alpha-adrenergic blocker indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating. It is available as capsules for oral use. MedsAcross supplies Phenoxybenzamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PhenoxybenzamineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Phenoxybenzamine hydrochloride prescribing information (Amneal Pharmaceuticals NY) · U.S. National Library of Medicine, DailyMed
Need Phenoxybenzamine 10 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.